Latest On Genus plc (GENSF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-02-29 05:27 EST | Dividend | A dividend of $0.1 has been announced on Feb 22, 2024. It will be paid Mar 28, 2024 with an ex-dividend date of Feb 29, 2024. | Neutral |  |
| 2023-11-09 05:05 EST | Dividend | A dividend of $0.22 has been announced on Sep 7, 2023. It will be paid Dec 8, 2023 with an ex-dividend date of Nov 9, 2023. | Neutral | |
| 2023-03-02 05:05 EST | Dividend | A dividend of $0.1 has been announced on Feb 23, 2023. It will be paid Mar 30, 2023 with an ex-dividend date of Mar 2, 2023. | Neutral | |
| 2023-02-25 15:59 EST | News | Genus plc (GENSF) Q2 2023 Earnings Call Transcript | N/A | |
| 2023-02-23 10:02 EST | News | Genus reports 1H'23 EPS, revenue up Y/Y | N/A | |
| 2022-11-17 05:05 EST | Dividend | A dividend of $0.22 has been announced on Sep 8, 2022. It will be paid Dec 9, 2022 with an ex-dividend date of Nov 17, 2022. | Neutral | |
| 2022-09-08 22:28 EST | News | Genus GAAP EPS of £0.82, revenue of £593.4M misses by £145.72M | N/A | |
| 2022-09-08 22:28 EST | News | Genus plc (GENSF) Q4 2022 Earnings Call Transcript | N/A | |
| 2022-03-03 05:06 EST | Dividend | A dividend of $0.1 has been announced on Feb 24, 2022. It will be paid Mar 31, 2022 with an ex-dividend date of Mar 3, 2022. | Neutral | |
| 2021-11-18 05:06 EST | Dividend | A dividend of $0.22 has been announced on Sep 9, 2021. It will be paid Dec 10, 2021 with an ex-dividend date of Nov 18, 2021. | Neutral | |
| 2021-03-04 05:15 EST | Dividend | A dividend of $0.1 has been announced on Feb 25, 2021. It will be paid Apr 1, 2021 with an ex-dividend date of Mar 4, 2021. | Neutral | |
| 2021-02-27 13:43 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-25 16:22 EST | News | Genus reports 1H results | N/A | |
| 2020-12-04 18:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-19 05:08 EST | Dividend | A dividend of $0.2 has been announced on Sep 8, 2020. It will be paid Dec 11, 2020 with an ex-dividend date of Nov 19, 2020. | Neutral | |
| 2020-11-08 02:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-11 10:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 10:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-09 07:54 EST | News | Genus reports FY results | N/A | |
| 2020-08-31 14:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 07:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 23:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 23:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-17 02:58 EST | Financials | Company financials have been released. | Neutral | |
About Genus plc (GENSF):
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. Genus plc has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
General
- Name Genus plc
- Symbol GENSF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 3,100
- Fiscal Year EndJune
- Web URLhttp://www.genusplc.com
View More
Valuation
- Trailing PE 65.57
- Forward PE 54.05
- Price/Sales (Trailing 12 Mt.) 6.43
- Price/Book (Most Recent Quarter) 6.96
- Enterprise Value Revenue 9.14
- Enterprise Value EBITDA 53.6
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin 9%
- Return on Assets 5%
- Return on Equity 9%
- Revenue Per Share $0
- Gross Profit 211.6 million
- Quarterly Earnings Growth 5.5%
View More
Highlights
- Market Capitalization 4.57 billion
View More
Share Statistics
- Shares Outstanding 65.3 million
- Shares Float 64.68 million
- % Held by Insiders 89%
- % Held by Institutions 75.21%
View More
Technicals
- Beta 0.15
- 52 Week High $76.89
- 52 Week Low $30.84
- 50 Day Moving Average 72.49
- 200 Day Moving Average 52.98
View More
Dividends
- Forward Annual Dividend Rate $0.4
- Forward Annual Dividend Yield 0.58%
- Payout Ratio 38%
- Dividend Date N/A
- ExDividend Date 2021-03-04
- Dividend Per Share $0.4
- Dividend Yield 0%
View More
Genus plc (GENSF) Dividend Calendar:
Genus plc pays out 38% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Genus plc (GENSF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | $0.33 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | $0.31 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | $0.16 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $135.35 million | $0.16 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $135.35 million | $0.24 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $124.85 million | $0.22 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $124.85 million | $0.14 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $119.4 million | $0.14 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $119.4 million | -$0.07 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $115.85 million | -$0.08 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $115.85 million | $0.01 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $119.3 million | $0.01 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $119.3 million | $0.46 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $118.5 million | $0.45 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $118.5 million | $0.26 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $111.05 million | $0.25 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $111.05 million | $0.08 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $0.08 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.42 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.46 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.13 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.13 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.25 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.24 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.25 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.27 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.16 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.16 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.23 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.23 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.10 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.10 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.21 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.20 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.27 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.28 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.23 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.23 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.18 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.18 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.20 | $0.00 |
Genus plc (GENSF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | 15.2 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 150000 |
| Gross Profit | N/A | N/A | N/A | N/A | 94.2 million |
| Ebit | N/A | N/A | N/A | N/A | -27.5 million |
| Operating Income | N/A | N/A | N/A | N/A | -27.5 million |
| Income Tax Expense | 4.2 million | 4.2 million | 2.15 million | 2.15 million | 3.15 million |
| Total Revenue | N/A | N/A | N/A | N/A | 135.35 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 41.15 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 42.7 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 12.05 million |
| Net Income Applicable to Common Shares | 15.75 million | 15.75 million | 8.4 million | 8.4 million | 11.85 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Oct 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | 800000 | N/A | 800000 |
| Change to Liabilities | 5.2 million | 5.2 million | 800000 | 800000 | 800000 |
| Total Cash Flow from Investing Activities | -8.7 million | -8.7 million | -6.65 million | -6.65 million | -6.65 million |
| Net Borrowings | -4.15 million | -4.15 million | 1.7 million | 1.7 million | 1.7 million |
| Total Cash Flow from Financial Activities | N/A | N/A | -4.4 million | N/A | -4.4 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | 300000 | N/A | 300000 |
| Total Cash from Operating Activities | 20.85 million | 20.85 million | 12.05 million | 12.05 million | 12.05 million |
| Depreciation | N/A | N/A | 8.05 million | N/A | 8.05 million |
| Other Cash Flow from Investing Activities | 1.15 million | 1.15 million | 700000 | 700000 | 700000 |
| Change to Inventory | N/A | N/A | -400000 | N/A | -400000 |
| Change to Account Receivables | N/A | N/A | -1.1 million | N/A | -1.1 million |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | -250000 | -250000 | -7.65 million | -7.65 million | -7.65 million |
| Capital Expenditures | N/A | N/A | 5.55 million | N/A | 5.55 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 360.9 million | N/A | 343.9 million |
| Total Stockholder Equity | N/A | N/A | 508.8 million | N/A | 496.2 million |
| Other Current Liabilities | 11.6 million | 11.6 million | 7.5 million | N/A | 13.8 million |
| Total Assets | N/A | N/A | 868.7 million | N/A | 839 million |
| Common Stock | 6.5 million | 6.5 million | N/A | N/A | 6.5 million |
| Other Current Assets | 1.1 million | 1.1 million | 39.8 million | 6.5 million | 500000 |
| Retained Earnings | 318.8 million | 318.8 million | 294 million | 294 million | 295.1 million |
| Other Liabilities | 97.1 million | 97.1 million | N/A | 106 million | 105.1 million |
| Other Assets | 299.5 million | 299.5 million | N/A | 315.6 million | 310.3 million |
| Cash | N/A | N/A | 41.3 million | N/A | 31.1 million |
| Total Current Liabilities | 122.9 million | 122.9 million | 130.2 million | N/A | 116.7 million |
| Other Stockholder Equity | -3.9 million | -3.9 million | N/A | 29.3 million | 15.7 million |
| Property, Plant & Equipment | 110 million | 110 million | N/A | 117.9 million | 107.8 million |
| Total Current Assets | 228.9 million | 228.9 million | 223.8 million | N/A | 211.2 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 31.1 million |
| Net Tangible Assets | 332.3 million | 332.3 million | N/A | 327 million | 317.6 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | 103.6 million | N/A | 100.4 million |
| Inventory | 73.2 million | 73.2 million | 37.4 million | N/A | 79.8 million |
| Accounts Payable | 92.5 million | 92.5 million | 95 million | N/A | 86.7 million |
Genus plc (GENSF) Chart:
Genus plc (GENSF) News:
Below you will find a list of latest news for Genus plc (GENSF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Genus plc (GENSF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Genus plc (GENSF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|